Kelly J. Clark, MD, MBA, DFAPA, DFASAM is the Founder and President of Addiction Crisis Solutions, a company focused on transforming addiction care into evidence-based, cost-effective practice. She is the recipient of the Leader of Consequence Award from the Fuqua School of Business and the John P. McGovern Award from the American Society of Addiction Medicine (ASAM) of which she is a past president.A sought-after national speaker and forensic expert, Dr. Clark's expertise in health care delivery systems, financing, and quality stand upon her vast breadth of clinical work throughout the care continuum and varied settings.A member of the Steering Committee of the National Academy of Medicine’s Action Collaborative on the US Opioid Epidemic and Co-Leader of the Research, Data, and Metrics Work Group and the Telehealth and Virtual Care Group, Dr. Clark is a co-author of “Guide for Future Directions for the Addiction and OUD Treatment Ecosystem”.Kelly has been Chief Medical Officer of two privately backed companies (Behavioral Health Group, CleanSlate Centers), as well as a medical director at a health plan (CDPHP, where she continues as a consulting medical director), CVS/Caremark, and a pharmaceutical company (Orexo/Touchpoint). She brings this unique background to addressing the needs of a range of stakeholder groups through ACS.Dr. Clark is a Director of DisposeRx, the leading solution in site of use drug disposal, and is a consultant to Bicycle Health, Within Health, Resilient BioScience, and Journey Colab. She hasr.Dr. Clark has provided her expertise to the US Presidential Opioid Commission, FDA, NIDA (Office of Translational Initiatives and Program Innovations), SAMHSA, the Office of Comptroller General; the FBI, DEA, OIG, as well as attorneys in divisions such as states AGs, AUSAs, US Trial Attorneys and the DOJ’s Civil Rights Division; ASTHO, National Safety Council, and National Business Group on Health; and numerous provider and payer organizations.She is a member of the MIlken Institute Public Health Advisory Board, was on psychiatric faculty of the University of Massachusetts Medical School and founding faculty at the VTC Carilion School of Medicine, and a founding member of the National Rx Drug Abuse and Heroin Summit Advisory Board.Specialties: Master of Business Administration with Additional Certification in Health Sector Management, the Fuqua School of Business at Duke University. Board Certified in Psychiatry by ABPN and Addiction Medicine by ABPM.